Literature DB >> 7358836

Rabies virus inactivation by binary ethylenimine: new method for inactivated vaccine production.

O P Larghi, A E Nebel.   

Abstract

The inactivation dynamics of rabies virus (PV strain) by binary ethylenimine, and the immunogenic properites and the stability of the vaccines prepared using this agent, were studied. Binary ethylenimine at a final concentration of 0.01 M was prepared wtih 2-bromoethylamine hydrobromide in alkaline solutions, either separately from or in suspensions of rabies virus propagated in BHK cells. The infectivity of virus suspensions containing more than 108 plaque-forming units per 0.1 ml was inactivated in 2 h when the inactivating agent was prepared before its addition to the suspensions, and in3 h when prepared directly in the suspensions. Liquid vaccines prepared in this manner and stored at different temperatures maintained potency for 1 month at 37 degrees C and for 6 months at 4 degrees C and 22 to 25 degrees C. Lyophilized vaccine maintained its potency for 6 months at the three temperatures. The inactivated vaccine mixed with aluminum or oil adjuvant at high dilutions protected guinea pigs against challenge. This safer procedure for rabies virus inactivation offers promise for the production of effective vaccines for the immunization of dogs and cattle.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7358836      PMCID: PMC273335          DOI: 10.1128/jcm.11.2.120-122.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Inactivation of viruses in serum with binary ethyleneimine.

Authors:  H G Bahnemann
Journal:  J Clin Microbiol       Date:  1976-02       Impact factor: 5.948

2.  GROWTH OF BABY HAMSTER KIDNEY CELLS IN SUSPENSION.

Authors:  P B CAPSTICK
Journal:  Proc R Soc Med       Date:  1963-12

3.  A new antirabies vaccine for human use; clinical and laboratory results using rabies vaccine made from embryonated duck eggs.

Authors:  F B PECK; H M POWELL; C G CULBERTSON
Journal:  J Lab Clin Med       Date:  1955-05

4.  Antigenicity of beta-propiolactone-inactivated virus vaccines.

Authors:  G A LOGRIPPO; F W HARTMAN
Journal:  J Immunol       Date:  1955-08       Impact factor: 5.422

5.  Comparison of pseudorabies virus inactivated by bromo-ethylene-imine, 60Co irradiation, and acridine dye in immune assay systems.

Authors:  I L Sun; D P Gustafson; G Scherba
Journal:  J Clin Microbiol       Date:  1978-11       Impact factor: 5.948

6.  Antigenic properties of rabies virus components.

Authors:  T J Wiktor; E György; D Schlumberger; F Sokol; H Koprowski
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

7.  Sensitivity of bhk-21 cells supplemented with diethylaminoethyl-dextran for detection of street rabies virus in saliva samples.

Authors:  O P Larghi; A E Nebel; L Lazaro; V L Savy
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

8.  Purified rabies vaccine: development and comparison of potency and safety with two human rabies vaccines.

Authors:  R K Sikes; O P Larghi
Journal:  J Immunol       Date:  1967-09       Impact factor: 5.422

9.  Reproducible plaquing system for rabies, lymphocytic choriomeningitis,k and other ribonucleic acid viruses in BHK-21-13S agarose suspensions.

Authors:  W D Sedwick; T J Wiktor
Journal:  J Virol       Date:  1967-12       Impact factor: 5.103

10.  Immunogenicity of rabies virus inactivated by -propiolactone, acetylethyleneimine, and ionizing irradiation.

Authors:  T J Wiktor; H G Aaslestad; M M Kaplan
Journal:  Appl Microbiol       Date:  1972-05
View more
  7 in total

1.  Interleukin 2 acts as an adjuvant to increase the potency of inactivated rabies virus vaccine.

Authors:  J H Nunberg; M V Doyle; S M York; C J York
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  Inactivation of infectious bursal disease virus by binary ethylenimine and formalin.

Authors:  M Habib; I Hussain; W H Fang; Z I Rajput; Z Z Yang; H Irshad
Journal:  J Zhejiang Univ Sci B       Date:  2006-04       Impact factor: 3.066

3.  A preliminary vaccine potency trial of a Newcastle disease virus inactivated with binary ethylenimine.

Authors:  C Buonavoglia; A Fioretti; M Tollis; F Menna; V Papparella
Journal:  Vet Res Commun       Date:  1988       Impact factor: 2.459

4.  Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques.

Authors:  Rebecca Broeckel; Julie M Fox; Nicole Haese; Craig N Kreklywich; Soila Sukulpovi-Petty; Alfred Legasse; Patricia P Smith; Michael Denton; Carsten Corvey; Shiv Krishnan; Lois M A Colgin; Rebecca M Ducore; Anne D Lewis; Michael K Axthelm; Marie Mandron; Pierre Cortez; Jonathan Rothblatt; Ercole Rao; Ingo Focken; Kara Carter; Gopal Sapparapau; James E Crowe; Michael S Diamond; Daniel N Streblow
Journal:  PLoS Negl Trop Dis       Date:  2017-06-19

5.  In vitro assessment of the feline cell-mediated immune response against feline panleukopeniavirus, calicivirus and felid herpesvirus 1 using 5-bromo-2'-deoxyuridine labeling.

Authors:  Ben L Vermeulen; Sabine E Gleich; Annelike Dedeurwaerder; Dominique A Olyslaegers; Lowiese M Desmarets; Hannah L Dewerchin; Hans J Nauwynck
Journal:  Vet Immunol Immunopathol       Date:  2012-03-10       Impact factor: 2.046

Review 6.  Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine.

Authors:  H G Bahnemann
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

7.  Sucrose density gradient centrifugation and cross-flow filtration methods for the production of arbovirus antigens inactivated by binary ethylenimine.

Authors:  Alyssa T Pyke; Debra A Phillips; Teck F Chuan; Greg A Smith
Journal:  BMC Microbiol       Date:  2004-01-14       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.